Evidence map›Paper›PMID 38335237›Full record

ArticlePLoS pathogens2024

SARS-CoV-2 Nsp1 cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA.

Ranen Aviner, Peter V Lidsky, Yinghong Xiao, Michel Tassetto, Damian Kim, Lichao Zhang, Patrick L McAlpine, Joshua Elias, Judith Frydman, Raul Andino

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ranen AvinerDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America.
Peter V LidskyDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America.
Yinghong XiaoDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America.
Michel TassettoDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America.
Damian KimChan Zuckerberg Biohub-San Francisco, San Francisco, California, United States of America.
Lichao ZhangChan Zuckerberg Biohub-San Francisco, Stanford, California, United States of America.
Patrick L McAlpineChan Zuckerberg Biohub-San Francisco, Stanford, California, United States of America.
Joshua EliasChan Zuckerberg Biohub-San Francisco, Stanford, California, United States of America.
Judith FrydmanDepartment of Biology and Department of Genetics, Stanford University, Stanford, California, United States of America.
Raul AndinoDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-5503-9349
University of California, San Francisco · USChan Zuckerberg Initiative (United States) · USStanford University · US

Funding

Translation Accelerator CoreU19AI171421 · NIAID · STANFORD UNIVERSITY · PI JEFFREY S GLENN · 2022 to 2026
$93.4M
PROTEIN FOLDING IN THE EUKARYOTIC CYTOSOLR01GM056433 · NIGMS · STANFORD UNIVERSITY · PI Judith Frydman · 1997 to 2026
$5.0M
Mapping spatiotemporal dynamics during enterovirus infection across cells and tissuesR01AI169460 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raul Andino, Luis J Sigal · 2022 to 2026
$4.5M
Mechanistic dissection of the link between virus infection and Alzheimer’s disease in a model organismR01AI137471 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDINO, RAUL · 2018 to 2022
$2.9M
Defining the role of Host Hsp70 Subnetworks in Dengue Virus ReplicationR01AI127447 · NIAID · STANFORD UNIVERSITY · PI FRYDMAN, JUDITH · 2017 to 2021
$2.4M
NIAID NIH HHS R01 AI127447NIAID NIH HHS R01 AI137471NIAID NIH HHS R01 AI169460NIAID NIH HHS U19 AI171421NIGMS NIH HHS R01 GM056433
6 · The paper itself

Abstract

A better mechanistic understanding of virus-host dependencies can help reveal vulnerabilities and identify opportunities for therapeutic intervention. Of particular interest are essential interactions that enable production of viral proteins, as those could target an early step in the virus lifecycle. Here, we use subcellular proteomics, ribosome profiling analyses and reporter assays to detect changes in protein synthesis dynamics during SARS-CoV-2 (CoV2) infection. We identify specific translation factors and molecular chaperones that are used by CoV2 to promote the synthesis and maturation of its own proteins. These can be targeted to inhibit infection, without major toxicity to the host. We also find that CoV2 non-structural protein 1 (Nsp1) cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA. When EIF1/1A are depleted, more ribosomes initiate translation from a conserved upstream CUG start codon found in all genomic and subgenomic viral RNAs. This results in higher translation of an upstream open reading frame (uORF1) and lower translation of the main ORF, altering the stoichiometry of viral proteins and attenuating infection. Replacing the upstream CUG with AUG strongly inhibits translation of the main ORF independently of Nsp1, EIF1, or EIF1A. Taken together, our work describes multiple dependencies of CoV2 on host biosynthetic networks and proposes a model for dosage control of viral proteins through Nsp1-mediated control of translation start site selection.

Indexed as

COVID-19RNA, ViralHumansPeptide Initiation FactorsSARS-CoV-2Viral ProteinsPeptide Initiation FactorsRNA, ViralViral Proteins

Identifiers

PMID38335237
PMCPMC10903962
OpenAlexW4391677511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.